# Reliance Pathway Report — V.9 Prompt (124 Countries)
_Prepared by Rex for use in RegDesk AI Assistant Chat_
_Created: 2026-07-08_

---

## PROMPT TO PASTE INTO THE AI ASSISTANT CHAT

---

Please generate the **Reliance Pathway Report for Medical Devices — V.9**, an updated and expanded version of the existing V.8 report (47 countries), now covering **all 124 countries** served by RegDesk.

---

### REPORT PARAMETERS

**Title:** Reliance Pathways & FSC/CGF Requirements for Medical Devices
**Subtitle:** Medical Device Registration Intelligence · 124 Countries · V.9 · [Month Year]
**File name:** `Reliance Pathway Report for Medical Devices_V.9.pdf`
**Format:** A4 Portrait, multi-page branded PDF using the RegDesk standard template

---

### THREE QUESTIONS TO ANSWER PER COUNTRY

For each country, research and answer the following three questions:

**Q1 — Does a reliance pathway exist?**
Answer: YES / NO / PARTIAL / GAP
- YES = an official, published reliance framework exists for medical devices
- PARTIAL = a reliance mechanism exists but is informal, limited in scope, or device class-specific
- NO = the country explicitly requires full independent registration (no reliance accepted)
- GAP = insufficient public data to determine; further research required

**Q2 — Description of the reliance pathway**
Provide a concise but complete description of:
- Which foreign approvals/registrations are recognized (e.g. FDA 510k/PMA, CE mark MDR, TGA, Health Canada, MHLW, etc.)
- Which device classes are eligible
- What the abridged pathway entails (e.g. reduced dossier, expedited review, direct recognition)
- Any key conditions or limitations

**Q3 — Is a Certificate of Free Sale (FSC) or Certificate of Good Manufacturing Practice (CGF/CGMP) required?**
Answer: YES / NO / PARTIAL / GAP
- Include specific notes: which certificate type, from which authority, any legalization/notarization requirements (Apostille, embassy stamp, TECO), validity period, and whether it substitutes or supplements other requirements.

---

### RESEARCH SOURCES (USE IN ORDER)

1. **RegDesk MCP backend** — query `search_regulations` (regulation_type=device) for each country first. Extract relevant content from CommonRegulations, Importation, and Registration sections.
2. **Official regulatory authority websites** — supplement or fill gaps using the country's primary medical device authority. Cite the specific page/document/article used.
3. **IMDRF country reports** — cross-reference where applicable.

Flag each answer as: **Confirmed (MCP)** / **Confirmed (official source)** / **Partial** / **Gap**

---

### COUNTRIES TO COVER (124 total)

#### Already researched in V.8 (keep and update if new info found):
Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Switzerland, Algeria, Croatia, Cyprus, Czech Republic, Ecuador, Estonia, Guatemala, Hong Kong, Hungary, India, Israel, Japan, South Korea, Lebanon, Lithuania, Malaysia, Malta, Mexico, Morocco, Peru, Saudi Arabia, Singapore, Slovenia, South Africa, Taiwan, Thailand, Tunisia, Turkey, United Kingdom, Uruguay, Bulgaria, Aruba, Bermuda, Curaçao, Guadeloupe, Guam, Martinique, N. Mariana Islands, Réunion

#### NEW countries to research and add (77):
**Europe (Western & Northern):**
Germany, France, Italy, Spain, Netherlands, Belgium, Austria, Portugal, Sweden, Denmark, Norway, Finland, Ireland, Greece, Luxembourg, Iceland, Liechtenstein

**Europe (Eastern & Balkan):**
Poland, Romania, Slovakia, Latvia, Lithuania (already in V8), Bosnia and Herzegovina, Serbia, Montenegro, Albania, North Macedonia, Kosovo, Moldova, Georgia, Armenia, Azerbaijan, Belarus, Ukraine, Russia

**Middle East & North Africa:**
United Arab Emirates, Kuwait, Qatar, Bahrain, Oman, Jordan, Egypt, Palestine, Iraq

**South & Southeast Asia:**
Pakistan, Bangladesh, Sri Lanka, Indonesia, Philippines, Vietnam, Myanmar, Cambodia, Laos

**Central Asia:**
Kazakhstan, Kyrgyzstan, Turkmenistan, Mongolia

**Oceania:**
New Zealand, Maldives, Mauritius

**Sub-Saharan Africa:**
Nigeria, Kenya, Ghana, Ethiopia, Tanzania, Rwanda, Uganda, Botswana, Namibia, Zimbabwe, Cameroon, Senegal, Côte d'Ivoire, Benin, Eswatini

**The Americas (additional):**
United States of America, Dominican Republic, Costa Rica, Honduras, El Salvador, Nicaragua, Panama, Jamaica, Venezuela, Paraguay, Bolivia, Guyana, Suriname, Cuba

**Central Asia / Other:**
Afghanistan, Yemen, Sudan

---

### REPORT STRUCTURE

**Page layout:** 9 countries per page (same as V.8)
**Total pages:** ~14 data pages + 1 summary page = ~15 pages

**Each data page contains a table with these columns:**
| Country | Q1 Reliance Pathway | Q2 Description | Q3 FSC/CGF Required | Reference Sources |

**Column specifications:**
- Country: flag emoji + country name, bold navy, 80px wide
- Q1 badge: YES (green) / NO (red) / PARTIAL (orange) / GAP (grey), centered, 60px wide
- Q2 Description: main cell, 11px Arial, full pathway description
- Q3 badge + note: badge centered (60px wide) + brief note below
- Sources: 10px, navy/italic, authority name + URL or document reference

**Final summary page:**
- KPI cards: Total Countries | Q1 YES count | Q1 PARTIAL count | Q1 NO count | Q1 GAP count | Q3 YES count
- Key observations (5–7 bullet points highlighting patterns, regional trends, notable findings)
- Regional breakdown table (Europe / Americas / Asia-Pacific / Middle East & Africa)

---

### DESIGN RULES (NON-NEGOTIABLE)

Follow the RegDesk Portrait Standard template exactly:

- **Header:** White background (#ffffff), navy title (#005594 bold), grey subtitle (#718096), RegDesk logo right-aligned (height 30px)
- **Accent bar:** Gradient line immediately below header: `linear-gradient(90deg, #005594 0%, #76cadd 40%, #fbc624 75%, #F16F12 100%)`
- **Page body:** Background #f1fafc, flex:1
- **Footer (every page):** White background, left: "Reliance Pathway Report · V.9 · Page X of Y", center: RegDesk logo (height 16px), right: full disclaimer verbatim
- **Disclaimer (verbatim, no abbreviation):** "© RegDesk 2026. This report is for informational purposes only and does not constitute legal or regulatory advice. Regulatory requirements are subject to change; always verify with official sources or the RegDesk Platform."
- **Page size:** `@page { size: A4 portrait; margin: 0; }` — pages are `794×1123px`, overflow hidden
- **Font:** Arial throughout
- **Table fonts:** body 11px, headers 11.5px, badges 7.5–8px bold, source text 10px
- **Badges:** rounded pill style, color-coded YES/NO/PARTIAL/GAP
- **No row splits across pages:** `tr { page-break-inside: avoid; }`
- **Column headers repeat on every page** the table spans: `thead { display: table-header-group; }`
- **NEVER** use Playwright `displayHeaderFooter` / `headerTemplate` — the `.page` shell handles all layout
- **NEVER** mention "Rex", "RegDesk DataManager", or any AI/bot name anywhere in the report

---

### OUTPUT

1. Generate the full HTML file (`reliance_v9.html`)
2. Render to PDF using Playwright (`reliance_v9.pdf`)
3. Generate PNG preview of first page (`reliance_v9_preview.png`)
4. Deliver:
   - PNG preview inline
   - PDF file to #data-report-tasks (topic 89) via Telegram
   - Or as download link if in webchat session

---

### NOTES FROM PREVIOUS VERSIONS

- **Argentina:** ANMAT reliance is bilateral with Brazil only (for medical devices). The general "recognized foreign authorities" list applies only to pharmaceuticals — NOT medical devices.
- **Brazil:** Recognized ERAs are IMDRF founder countries. Mexico (COFEPRIS) is NOT a recognized ERA for Brazil.
- **China:** Standard pathway = full NMPA registration. Exception: IVD Green Channel for Malaysia (July 2025).
- **Switzerland:** CE mark alone is sufficient — no official reliance document published by Swissmedic.
- **UK:** IRP framework launched 2025; CE mark transitional to 2028–2030; FSC required for EXPORTS only (not imports).
- **Taiwan:** FSC must be within 2 years, TECO notarization required (except USA/Canada/Australia).
- **EU member states** (Germany, France, Italy, Spain, etc.): these all follow EU MDR/IVDR. The reliance pathway question should be answered at the EU level, with country-specific notes only where national agencies add requirements (e.g. notified body country, national language labeling).

---